Collagenase is a Common Treatment of MCP and PIP Joint Contractures in Dupuytrens Disease

NCT03331926 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 199

Last updated 2020-04-22

No results posted yet for this study

Summary

To evaluate the effect of collagenase clostridium histolyticum treatment at the Department of Orthopaedic surgery at Horsens Regional Hospital after minimum one-year follow-up (FU).

Conditions

  • Dupuytren Contracture

Interventions

DRUG

Xiapex

Follow-up of effect of treatment

Sponsors & Collaborators

  • Jeppe Lange

    lead OTHER

Principal Investigators

  • Charlotte Hartig-Andreasen, MD, PhD · Regionshospitalet Horsens

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2017-01-01
Primary Completion
2017-05-31
Completion
2019-12-31

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03331926 on ClinicalTrials.gov